40多岁男性的基线前列腺特异性抗原（PSA）检测：40至50岁平均风险男性不应常规进行检测。 - Suppr | 超能文献

Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed.

作者信息

Carter H Ballentine

出版信息

Oncology (Williston Park). 2014 Feb;28(2):155-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed.40多岁男性的基线前列腺特异性抗原（PSA）检测：40至50岁平均风险男性不应常规进行检测。

Oncology (Williston Park). 2014 Feb;28(2):155-6.

2

Baseline PSA testing for men in their 40s: currently available evidence strongly supports baseline PSA measurements in this age group.40多岁男性的基线前列腺特异性抗原（PSA）检测：现有证据有力支持对该年龄组进行基线PSA测量。

Oncology (Williston Park). 2014 Feb;28(2):154, 156.

3

Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials.40-64 岁男性的前列腺特异性抗原检测：临床试验发表的影响。

J Natl Cancer Inst. 2013 May 15;105(10):743-5. doi: 10.1093/jnci/djt039. Epub 2013 Mar 4.

4

Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践：2007 - 2014年

BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.

5

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.美国预防服务工作组建议反对前列腺癌筛查后，对前列腺特异性抗原筛查、前列腺活检和前列腺癌治疗的相关情况。

Cancer. 2018 Jul 1;124(13):2733-2739. doi: 10.1002/cncr.31337. Epub 2018 May 21.

6

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.一项关于临床显著前列腺癌早期检测的随机试验（ProScreen）：研究设计和原理。

Eur J Epidemiol. 2017 Jun;32(6):521-527. doi: 10.1007/s10654-017-0292-5. Epub 2017 Jul 31.

7

Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions.2011 年至 2017 年，使用大型商业索赔数据库对 30 至 64 岁男性进行前列腺特异性抗原检测在美国的应用：对实践干预的影响。

Cancer Rep (Hoboken). 2021 Aug;4(4):e1365. doi: 10.1002/cnr2.1365. Epub 2021 May 2.

8

US guideline may have led to drop in PSA testing among primary care physicians, studies find.研究发现，美国指南可能导致基层医疗医生进行前列腺特异抗原（PSA）检测的次数减少。

BMJ. 2015 May 28;350:h2906. doi: 10.1136/bmj.h2906.

9

Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.美国 65 岁及以上男性中前列腺特异性抗原（PSA）检测的使用：对实践干预的影响。

Cancer Rep (Hoboken). 2021 Aug;4(4):e1352. doi: 10.1002/cnr2.1352. Epub 2021 May 1.

10

Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.前列腺特异性抗原检测的应用因人而异。

JAMA Intern Med. 2016 Apr;176(4):547-8. doi: 10.1001/jamainternmed.2015.8104.